Jointly

Jointly

PRE-SALE ENDED
13,223 Views
The Jointly platform, designed by the JP company, allows people to invest into the ICO system using the group-investing method.

In this way, financers can obtain valuable bonuses and a major amount of tokens just by investing an amount of funds that equal (in terms of value) to a single investment.

This procedure is completely decentralized and is made possible thanks to the Smart-Contract method, which will automatically manage the ICO investment and its result, i.e. the tokens distribution together with its bonuses, ending in the investor’s wallet.
7.9
TOTAL SCORE
8.5
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
Pre-sale Time: 01 June 2018 - 23 June 2018
Whitelist/KYC: Whitelist + KYC
Country: Italy
Token info
Ticker: JPT
Platform: Ethereum
Token Type: ERC20
Available for sale: 40,000,000 JPT (80%)
Financial
Pre-sale Price : 1 JPT = 0.24 EUR
ICO Price: 1 JPT = 0.4 EUR
Accepting: ETH
Soft cap: 100,000 EUR
Hard cap: 10,000,000 EUR
October 2017
- Concept <br /> <br /> - Research Developers
November 2017
Smart contract programming
January 2018
- Complete Smart-contract<br /> <br /> - Announce platform to the public
Mar 2018
Start develop web platform
jun 2018
integrate samrt-contract with web platform
August 2018
lunch platform
long term
-develop mobile app<br /> <br /> -internal wallet integration and FIAT / Crypto direct exchange<br /> <br /> -new projec
Screenshots taken on 11 May 2018
PierFilippo Bellucci
Founder
Participates in a number of projects
Jacopo Venturi
Founder
Participates in a number of projects
Alessandro Gasparri
Developer and Blockchain Expert
Participates in a number of projects
Gabriele Fedi
Developer and Blockchain Expert
Participates in a number of projects
Deniz Koxha
Marketing and relationship
Participates in a number of projects

Advisors (4)

Simon Cocking
Advisor
Participates in a number of projects
Bogdan Fiedur
Advisor
Participates in a number of projects
Taylor Conston
Advisor
Participates in a number of projects
Do Yeop Kim
Advisor
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Little Phil
Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.
Upcoming
Quarteria
Our mission is to create the first international decentralized residential and commercial real estate listings database controlled by both Buyers and Sellers. Real Estate Brokers and self-represented Sellers will be able to upload their listings and eventually, transfer title of properties, all paid for via the PROQ token.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
DocTailor
DocTailor is a unique self customizing smart legal contract platform, that allows, lawyers, individuals and organizations to send and create legal tailor-made smart contracts and agreements on the blockchain without developer experience.Bridging the gap between the trillion dollar crypto economy market.
Upcoming
Ispolink
Ispolink is cutting-edge automated matchmaking job board platform that leverages Blockchain and Artificial Intelligence (AI) technology to address one of the most fundamental challenges that exist nowadays – sourcing and attracting qualified personnel. We strive to empower companies operating in the blockchain and IT domain to fill their positions by providing them a full spectrum of tools to conduct and manage in-house the entire recruitment process efficiently - ranging from candidate sourcing, screening, through the various stages of interviews until the final offer, eliminating the need of intermediaries such as HR agencies. As per the job seekers, the platform is tailored to improve their overall experience by reducing the prolonged job searching, the endless waiting for feedback, coupled with convenience to receive the best offers with only a few clicks. Ispolink’s blockchain based product facilitates the processes for filling roles by providing a full cycle recruitment system. The platform will make the entire recruitment process more transparent, optimized, automated and also to help organizations to enhance their internal communication which will result in substantial cost and time reductions
Upcoming
MeFy
Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.